Testing effectiveness (Phase 2)Study completedNCT02664415
What this trial is testing
Safety and Therapeutic Efficacy of the VRC01 Antibody in Patients Who Initiated Antiretroviral Therapy During Early Acute HIV Infection
Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 23